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PARK20, an early onset autosomal recessive parkinsonism is due to mutations in the
phosphatidylinositol-phosphatase Synaptojanin 1 (Synj1). We have recently shown that
the early endosomal compartments are profoundly altered in PARK20 fibroblasts as well
as the endosomal trafficking. Here, we report that PARK20 fibroblasts also display a
drastic alteration of the architecture and function of the early secretory compartments.
Our results show that the exit machinery from the Endoplasmic Reticulum (ER) and the
ER-to-Golgi trafficking are markedly compromised in patient cells. As a consequence,
PARK20 fibroblasts accumulate large amounts of cargo proteins within the ER, leading
to the induction of ER stress. Interestingly, this stressful state is coupled to the activation
of the PERK/eIF2α/ATF4/CHOP pathway of the Unfolded Protein Response (UPR). In
addition, PARK20 fibroblasts reveal upregulation of oxidative stress markers and total
ROS production with concomitant alteration of the morphology of the mitochondrial
network. Interestingly, treatment of PARK20 cells with GSK2606414 (GSK), a specific
inhibitor of PERK activity, restores the level of ROS, signaling a direct correlation between
ER stress and the induction of oxidative stress in the PARK20 cells. All together, these
findings suggest that dysfunction of early secretory pathway might contribute to the
pathogenesis of the disease.
Keywords: PARK20, PERK (PKR-like endoplasmic reticulum kinase), oxydative stress, ER stress, Synaptojanin 1,
membrane trafficking, mitochondrial dysfunction, Parkinson’s disease
INTRODUCTION
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized
by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (Gao
and Hong, 2011; Cannon and Greenamyre, 2013; Beitz, 2014; Feng et al., 2015). A combination
of environmental and genetic factors has been considered to concur to the neuronal death.
However, the exact molecular mechanisms are still unknown. Notwithstanding, the alteration of
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mitochondrial function (Winklhofer and Haass, 2010; Pilsl and
Winklhofer, 2012), of reactive oxygen species (ROS) homeostasis
(Gaki and Papavassiliou, 2014; Al Shahrani et al., 2017; Guo et al.,
2018; Paladino et al., 2018) as well as the dysregulation of protein
folding control and/or autophagic flux (McNaught and Olanow,
2006; Malkus et al., 2009; Karabiyik et al., 2017; Remondelli and
Renna, 2017) have been implicated in PD pathogenesis.
Among genetic PD, PARK20 is a rare autosomal recessive
juvenile Parkinson’s form due to mutations in Synaptojanin1
(Synj1), a phosphatidylinositol phosphatase (PtdInsPP) (Krebs
et al., 2013; Quadri et al., 2013; Olgiati et al., 2014).
The homozygous R258Q mutation was almost simultaneously
reported in three unrelated families from Iran and Italy (Krebs
et al., 2013; Quadri et al., 2013; Olgiati et al., 2014). Subsequently,
the p.R459P mutation was found in an Indian family (Kirola
et al., 2016); and, more recently, another Iranian kindred has
been described with the p.R839C mutation (Taghavi et al., 2018).
Finally, a frameshift mutation (p.S552Ffs∗5) in heterozygous state
with the benign p.T1236M missense variant has been identified
in one late onset PD patient from Moroccan consanguineous
parents (Bouhouche et al., 2017), correlating Synj1 lesions to the
risk of PD development.
Synj1 is a highly conserved PtdInsPP existing in two isoforms:
the 145-kDa neuronal isoform and the ubiquitous 170-kDa
isoform (Ramjaun and McPherson, 1996). Synj1 function relies
on two sequential PtdInsPP domains: the N-terminal Sac1
and the central 5-phosphatase domains (5′-PP) (Di Paolo
and De Camilli, 2006). The Sac1 domain of Synj1 acts on
PtdIns 3- and 4-monophosphate, which are enriched in the
endosomal and Golgi membranes respectively (Guo et al.,
1999). Instead, the 5′-PP domain of Synj1 dephosphorylates
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] located in
the plasma membranes (McPherson et al., 1996; Cremona et al.,
1999). Additionally, the Synj1 protein also contains a COOH-
terminal proline rich region that retains the ability to interact
with SH3 domains of a variety of proteins that regulate its
subcellular localization and function (McPherson et al., 1996;
Dittman and Ryan, 2009).
Thanks to its double enzymatic activity, Synj1 exerts multiple
roles in dependence on the cell context. In nerve terminals,
Synj1 participates to the control of synaptic vesicles retrieval
(McPherson et al., 1996; Song and Zinsmaier, 2003; Mani
et al., 2007) and cooperates with DNAJC6, another PD-causative
gene (PARK19), in the process of clathrin disassembly from
synaptic vesicles during endocytosis (Chang-Ileto et al., 2011;
Edvardson et al., 2012). Proper Synj1 activity is essential to
control homeostasis and function of early endocytic pathways
in different cell types, including neuronal cells (Fasano et al.,
2018). Consistently, early endosomes of PARK20 fibroblasts
resulted enlarged and the recycling trafficking impaired (Fasano
et al., 2018). On the other hand, unbalanced Synj1 expression is
significantly involved in a number of neurological and psychiatric
disorders, such as: Bipolar Disorder (Saito et al., 2001; Stopkova
et al., 2004), Down’s Syndrome and Alzheimer’s Disease (Berman
et al., 2008; Voronov et al., 2008; Chang and Min, 2009;
Cossec et al., 2012; Martin et al., 2014), unraveling a critical
role in neurons.
The p.R258Q mutation into the Synj1 Sac1 domain was shown
to abolish either the 3- or 4- phosphatase activity, while it does not
affect the 5-phosphatase activity (Krebs et al., 2013). Therefore,
the loss of Sac1 function could alter the rate of PtdIns3P and
PtdIns4P, two crucial PtdInsPs for the control of structure and
function of endosomal (Efe et al., 2005; Di Paolo and De Camilli,
2006) and ER or Golgi complex membranes (De Matteis and
D’Angelo, 2007; D’Angelo et al., 2008), respectively. Moreover,
as we have recently shown, Sac1 domain is necessary for proper
endosomal trafficking and at least 50% of its activity is required
to ensure correct functionality (Fasano et al., 2018).
Here, we investigated whether p.R258Q mutation in the Sac1
domain of Synj1 could also influence vesicular trafficking at the
early stages of the secretory pathway. Our experiments show
that the ER exit machinery and the ER-to-Golgi trafficking
are markedly compromised in p.R258Q mutated cells. As a
consequence, PARK20 fibroblasts accumulate larger amounts of
cargo proteins within the ER. This condition, referred to as ER
stress, activates the PERK/eIF2α/ATF4/CHOP pathway of the
Unfolded Protein Response (UPR) and induces oxidative stress
and mitochondrial damage.
MATERIALS AND METHODS
Cell Cultures
Fibroblasts were derived directly from the skin punch biopsies
of the two Italian patients carrying the p.R258Q mutation at
homozygous state (Quadri et al., 2013; Olgiati et al., 2014).
A written informed consent was obtained from each patient. As
control cells, primary adult Human Dermal Fibroblasts (HDF)
were purchased from Sigma-Aldrich. PARK20 fibroblasts and
HDF were grown in one ready-to-use Fibroblast Growth Medium
(FGM from Sigma-Aldrich) at 37◦C and 5% CO2 in humidified
atmosphere. Experiments were performed on both cell lines at
similar culture passages (P5-P6). When indicated, cells were
starved in Fibroblasts Basal Medium (FBM from Sigma-Aldrich),
which does not contain FBS and growth factors supplement.
Drug treatments were performed with 1 µM GSK2606414
(Calbiochem) or 500 nM Thapsigargin (Sigma-Aldrich) for
the indicated time.
Immunofluorescence
Cells seeded on glass cover slips were washed in phosphate-
buffered saline (PBS), fixed in PBS-4 % paraformaldehyde and
permeabilized 30 min in PBS containing 0.5% BSA, 0.005%
saponin and 50 mM NH4Cl. Cells were immunostained with the
following primary antibodies: rabbit polyclonal anti-ERGIC-53
(α-CT) (Spatuzza et al., 2004), mouse monoclonal anti-GM130
(BD Biosciences), rabbit polyclonal anti-Giantin (Abcam),
rabbit plyclonal anti-KIAA0310 (Bethyl Laboratories), rabbit
polyclonal anti-Sec31a, rabbit plyclonal anti-Sar1 (Millipore),
rabbit polyclonal anti-collagen IV (Rockland immunochemicals),
mouse monoclonal anti-KDEL (StressGen). Primary antibodies
were detected with Alexa 488- and Cy3-conjugated antibodies
(Jackson Immuno Research Laboratories).
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For mitochondria staining, cells were incubated for 30 min
at 37◦C with 200 nM Mitotracker Red CMXRos (Invitrogen-
Molecular Probes) in FBM before fixing in cold acetone for
5 min on ice. Images were acquired on a laser scanning confocal
microscope (TCS SP5; Leica MicroSystems or LSM 510 Meta;
Zeiss MicroSystems) equipped with a plan Apo 63X, NA 1.4 oil
immersion objective lens. Quantitative analysis was performed
on a minimum of 30 cells by setting the same threshold of
fluorescence intensity in all the samples analyzed.
Co-localization analyses and the mean intensity fluorescence
quantification were carried out by using either the Leica SP5 or
Zeiss software or the ImageJ program as previously described
(Paladino et al., 2008; Gorrasi et al., 2014; Iorio et al., 2018;
Ranieri et al., 2018). Briefly, the number of co-localized pixels
was normalized for the total fluorescent pixels in the image.
The degree of colocalization was assessed by calculating the
Pearson’s correlation coefficient. Mean fluorescence intensity was
measured in Region of Interest (ROI) of equal area in control
and PARK20 samples. The number and size of SEC31a and
SEC16a fluorescent spot was measured by using the ImageJ
program. The distance from the nucleus of ERGIC-53 fluorescent
spots was measured by using the scale bar drawing tool of
Leica SP5 software.
Electron Microscopy
Cells were fixed in 1% glutaraldehyde dissolved in 0.2 M HEPES
buffer (pH 7.4) for 30 min at room temperature and then post-
fixed with a mixture of 2% OsO4 and 100 mM phosphate buffer
(pH 6.8) (1 part 2% OsO4 plus 1 part 100 mM phosphate buffer)
for 25–30 min on ice. Then, the cells were washed three times
with water and incubated with 1% thiocarbohydrizide diluted
in H2O for 5 min, incubated in a mixture of 2% OsO 4 and
3% potassium ferrocyanide (1 part 2% OsO4 plus 1 part 3%
potassium ferrocyanide) for 25 min on ice and overnight at
4◦C in 0.5% uranyl acetate diluted in H2O. After dehydration
in graded series of ethanol, the cells were embedded in epoxy
resin and polymerized at 60◦C for 72 hr. Thin 60 nm sections
were cut at the Leica EM UC7 microtome. EM images were
acquired from thin sections using a FEI Tecnai-12 electron
microscope equipped with a VELETTA CCD digital camera (FEI,
Eindhoven, Netherlands).
Western Blotting
Actively growing cells seeded on 60 mm dishes were starved in
FBM for 18 h prior to be subjected to the indicated treatments.
Cells were then harvested in lysis buffer (10 mM Tris-HCl
pH7.4, 150 mM NaCl, 1 mM EDTA pH 8.0, 1% Triton X-100)
supplemented with protease and phosphatase inhibitor cocktail
(Roche). Equal amounts of protein extracts were analyzed by 8
or 10% SDS-PAGE and transferred on Protran nitro-cellulose
membranes (Schleicher and Schuell). Membranes were blocked
either in PBS containing 10% non-fat dry milk and 0.1% Tween-
20, or in TBS containing 5% BSA and 0.1% Tween-20, depending
on the antibody used.
Membranes were cut in stripes according to the molecular
weight expected for the single proteins analyzed, incubated with
the primary followed by secondary antibodies and then visualized
by ECL reaction (Amersham International) (see Supplementary
Figures S3, S4). The following primary antibodies were used:
rabbit monoclonal anti-PERK (Cell Signalling Technology),
rabbit polyclonal anti-eIF2α and anti-phospho-eIF2α (Cell
Signalling Technology), rabbit monoclonal anti-ATF4 (Abcam),
mouse monoclonal anti-GADD153 (Santa Cruz Biotechnology),
mouse monoclonal anti-HO1 (Santa Cruz Biotechnology) and
mouse monoclonal anti-α Tubulin (Santa Cruz Biotechnology).
HRP-conjugated IgG (Jackson Immuno Research Laboratories)
were used as secondary antibodies. Filters were exposed to
ChemiDoc MP System (Bio-Rad Laboratories Inc.) and the
densitometry analysis of autoradiographs was performed by the
ImageJ program on three independent experiments.
Oxidative Stress Assays
106 cells for each treatment were disposed in a well of BD
Falcon 96-well black plates and starved in FBM for 18 h prior
to be subjected to the indicated treatments. Cytosolic ROS
were quantified by a fluorescence microplate reader [Tecan
Infinite 200 Pro] using dihydrorhodamine 123 (DHR 123) probe
(Santa Cruz Biotechnology), a cell-permeable non-fluorescent
substance that undergoes intracellular oxidation in the presence
of ROS. In detail, cells were incubated for 1 h with 50 µM of
DHR123/HBSS and then washed two times with freshly prepared
Hank’s balanced salt solution. Subsequently, formation of DHR
123 has been monitored by fluorescence spectroscopy using
excitation and emission respectively of 500 L nm and 536 L
nm. In some experiments, cells were pre-incubated with 1 µM
GSK2606414 for 2 h, before measurements. Fluorescence signals
have been recorded using Tecan i-control software and expressed
as arbitrary units.
In another approach, we measured the ROS on single-
cells. To this purpose, cells grown on glass bottom dishes
were incubated with 2′,7′-dichlorodihydrofluorescein diacetate
(DCFH-DA, 10 µM) for 10 min at 37◦C in culture medium
without serum and, then, imaged in vivo in CO2 independent
medium as previously described (Piccoli et al., 2013). Images were
collected by a Zeiss confocal LSM510 using Ar–Kr laser beam
(λex 488 nm); same laser power and same settings were used
for control and patient fibroblasts in all experimental conditions.
Data are expressed as arbitrary units of fluorescence and reported
as mean± SD from three independent experimental conditions.
For NADPH oxidase activity measurement, the lucigenin-
enhanced chemioluminescence assay was used to determine
NADPH oxidase-mediated superoxide radical (O2−) production
as previously described (Carrizzo et al., 2017; Schiattarella
et al., 2018). Cells, cultured in 100 mm dishes, were detached
using 0.25% trypsin/EDTA (1 mmol/l), washed with PBS, and
resuspended in modified HEPES buffer containing (mmol/l)
NaCl 140, KCl 5, MgCl2 0.8, CaCl2 1.8, Na2HPO4 1, HEPES
25 and 1% glucose, pH 7. Subsequently, cells were homogenated
using VWR pellet mixer [#431-0100] and 100 µg of extract were
distributed on a 96-well microplate. The reaction was started
by the addition of NADPH (0.1 mmol/l) to each well (250 µl
final volume) and lucigenin (5 µmol/l). The luminescence was
measured using Tecan Infinite M200 multimode microplate
fluorometer at 37◦C every 10 s for 60 min. Each experiment
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was performed in triplicate. In some experiments, cells were pre-
incubated with 1 µM GSK2606414 for 2 h, before measurement
of luminescence.
RT-PCR and XBPI Splicing Assay
One microgram of DNAse-treated total RNA was retro-
transcribed with the Easy-script plus cDNA synthesis Kit (abm)
according to manufacturer instructions. Semi-quantitative PCR
was performed on 3 µl of cDNA with the following primers
Bip/Grp78-forward: 5′-CTG GGT ACA TTT GAT CTG ACT
GG-3′; Bip/Grp78-reverse: 5′-GCA TCC TGG TGG CTT TCC
AGCCAT TC-3′; GAPDH-forward: 5′-GAA GGT GAA GGT
CGGAGT C-3′; GAPDH-reverse: 5′-GAA GATGGT GAT GGG
ATTTC-3′ (Amodio et al., 2011). XBPI splicing assay was
performed as previously described (Eletto et al., 2016) by using
the following primers: 5′-A AAC AGA GTA GCA GCT CAG
ACT GC-3′ and 5′-C CTT CTG GGT AGA CCT CTG GGA
G-3′. The resulted un-spliced and spliced XBP1 mRNA were
separated by gel electrophoresis on 3% agarose gel. Ethidium
bromide-stained amplicons were quantified by densitometry with
ImageJ software.
Statistical Analysis
Data are expresses as mean ± SD. All statistical analyses using
Student’s t-test and histograms were completed with Prism
statistical software (Graphpad, La Jolla, CA, United States)
and differences were considered statistically significant
when P < 0.05.
RESULTS
PARK20 Fibroblasts Show Unbalanced
ER-to-Golgi Trafficking and Abnormal
Structure of Golgi Membranes
To test whether membrane trafficking from the ER to the Golgi
complex was affected by the p.R258Q mutation, we analyzed
fibroblasts derived from homozygous R258Q/R258Q PARK20
patients and from healthy individuals.
Dynamics of membrane trafficking at the early steps of the
secretory pathway were analyzed by looking at the intracellular
distribution of vesicles carrying the cargo receptor ERGIC-53
(Appenzeller et al., 1999). Normally, the ERGIC-53 protein cycles
between the ER and the Golgi complex (Appenzeller et al., 1999)
and ERGIC-53 containing vesicles show their typical punctuate
distribution depicted by higher concentration in the region closed
to the cis-Golgi membranes, which in turn are labeled with
the resident protein GM130 in wild-type cells (Figure 1A, wt).
Instead, in patient fibroblasts ERGIC-53 vesicles were reduced
both in size and fluorescence intensity (Figure 1A, PARK20).
In addition, they are delocalized throughout the cytoplasm at
higher distance from the perinuclear region with a mean value
of 12.3 ± 3.4 µm in the PARK20 cells vs. 31.8 ± 4.3 µm in
the control cells (Figure 1C). Interestingly, ERGIC53 vesicles
redistribution pattern in the PARK20 cells overlapped with the
membrane network of the ER, as shown by the fluorescence
detected by the anti-KDEL antibody, which label ER resident
proteins bearing the KDEL retrieval sequence (Figure 1B). In
addition, we also detected dramatic changes in the organization
of Golgi membranes of PARK20 fibroblasts (Figures 1A,D). Both
the cis-Golgi membranes labeled by the resident protein GM130
(Figure 1A) and the overall Golgi architecture revealed by the
structural Golgi protein giantin (Figure 1D) were more dispersed
and relocated in tubular structures extending from the nucleus
to the cell edge in the PARK20 cells with respect to control
(Figures 1A,D). The ultrastructural analysis further showed that
the Golgi complex is scattered throughout the cell in PARK20
fibroblasts (Figure 1E, arrows). Moreover, while GM130 co-
localized almost completely with giantin in control cells, they
resulted partially co-distributed in patient cells (Figure 1D).
Since both GM130 and giantin are involved in the ER-to-Golgi
trafficking (Alvarez et al., 2001), these results further suggest that
PARK20 cells undergo unbalanced trafficking at the early steps of
the secretory pathway.
PARK20 Fibroblasts Show Reduced
Formation of COPII Carrier Vesicles
The results described above prompted us to test whether the
abnormal organization of post-ER compartments observed in the
PARK20 cells was the result of reduced flow of carrier vesicles
budding from the ER. Formation of transport vesicles from
the ER membranes requires the assembly of the vesicular coat
(COPII) at specific ER membrane domains defined ER exit Sites
(ERESs), recognized by the presence of the endogenous Sec16
protein (isoform A). As a rule, Sec16 recruits COPII components
for their assembly at the ERESs (Watson et al., 2006). As
expected, these latter are visible as punctuate structures dispersed
throughout the cytoplasm (Figure 2A, Sec16/wt). Instead, in
PARK20 cells the number of puncta of Sec16 fluorescence are
reduced (Figures 2A,B; Sec16/PARK20), indicating that the
number of ERESs is considerably decreased in PARK20 cells. As a
consequence, the number of COPII vesicles, revealed by antibody
recognizing Sec31 (Figure 2A, Sec31/wt), a component of the
outer layer of the COPII vesicles, was also reduced (Figures 2A,B;
Sec31/PARK20). Moreover, Sec16 co-localized with Sec31 at the
same extent as in control cells (Figure 2A, merge), suggesting
that Sec16 still organizes COPII assembly at ERESs, but with
less efficiency.
Thus, our results strongly indicate that the Synj1 activity
localized in the Sac1 domain of the protein is essential for the
proper function of COPII. In particular, the reduced number
of ERES found in the PARK20 cells indicates that altered
phosphatase activity of the Synj1 Sac1 domain reduces the
amount of ER exit sites, thus biasing the assembling and/or the
stability of COPII vesicles.
The Secretion of Collagen IV Is Impaired
in PARK20 Fibroblasts
To test whether reduced formation of ERESs could have an effect
on the rate of cargo proteins transport from the ER to the Golgi
complex, we examined the level of distribution of endogenous
collagen IV (COLIV) along the secretory pathway in PARK20
Frontiers in Neuroscience | www.frontiersin.org 4 June 2019 | Volume 13 | Article 673
fnins-13-00673 June 27, 2019 Time: 15:17 # 5
Amodio et al. UPR and Oxidative Stress in PARK20
FIGURE 1 | Protein markers of the early secretory pathway are differently distributed in WT and PARK20 fibroblasts. (A,B,D) HDF (WT) and PARK20 cells were
seeded on glass coverslips, fixed and processed for immunofluorescence with the indicated antibodies. Images were collected by confocal microscope. Scale bars:
10 µm. (C) Histogram shows the distance (mean ± SD in µM) from the nucleus of ERGIC-53 fluorescent spots. N ≥ 30. ∗∗p ≤ 0.01, Student’s t-test.
(E) Representative ultrastructural images of WT and PARK20 cells. Scale bar: 1 µm; arrows indicate the position of Golgi complex.
cells vs. control cells (Figure 3A). Typically, in normal fibroblasts
COLIV is secreted from the cell and accumulates in structures
located in the interstitial space out of the cell (Figure 3A,
COLIV/wt) (Amodio et al., 2016). In PARK20 fibroblasts, COLIV
was mainly found within intracellular membranes resembling the
ER network stained by the KDEL antibody (Figure 3A: compare
PARK20 pro-COLIV to KDEL), indicating that COLIV secretion
is reduced. In PARK20 fibroblasts, COLIV did not accumulate
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FIGURE 2 | The formation of COPII-coated vesicles are reduced in PARK20 fibroblasts. (A) HDF (WT) and PARK20 cells seeded on glass coverslips were fixed,
stained with the indicated antibodies and analyzed by confocal immunofluorescence. Scale bars: 10 µm. (B) Histogram shows particle count (mean ± SD) of Sec31
(green) and Sec16 (red) fluorescent spots analyzed by Image J. N ≥ 30. ∗p ≤ 0.05, ∗∗p ≤ 0.01, Student’s t-test.
FIGURE 3 | The secretion of collagen IV is impaired in PARK20 fibroblasts. (A) HDF (WT) and PARK20 cells were seeded on glass coverslips, processed for
immunofluorescence and analyzed by confocal imaging. Numbers on the right refers to Pearson’s correlation coefficient, quantified with Leica SP5 software
(mean ± SD). p ≤ 0.01, Student’s t-test; N ≥ 30; scale bars: 10 µm. (B) Histogram shows the percent of collagen IV pixels colocalizing with KDEL pixels
(mean ± SD) analyzed by Leica SP5 software. ∗∗p ≤ 0.01, Student’s t-test.
outside the cell (Figure 3A, PARK20), but it was mainly found
within intracellular membranes, in structures that resemble the
ER network stained by the KDEL antibody (Figure 3A: compare
PARK20 pro-COLIV to KDEL). Consistently, by analyzing the
rate of colocalization with ER resident proteins labeled by the
anti-KDEL antibody, we found an increase in procollagen IV
(pro-COLIV) colocalization with ER membranes: 87.1 ± 7.7%
in the Synj1 mutated cells compared to 56.6 ± 13.3% in
control cells (Figure 3B). In line with the immunofluorescence
assays, we found that secretion of COLIV by PARK20 fibroblasts
into culture medium was strongly reduced in comparison to
control fibroblasts (Supplementary Figure S1A). All these data
indicate that secretion of COLIV in the PARK20 cells was
almost completely inhibited presumably as a consequence of the
reduced function of the ER exit machinery. Moreover, a slight
but appreciable reduction of total protein secretion is observed
in PARK20 fibroblasts as well as a reduction of total delivery
to the surface (Supplementary Figure S1), all suggesting an
impairment of secretory trafficking.
The PERK/eIF2a/ATF4 Branch of the
Unfolded Protein Response Is Activated
in PARK20 Fibroblasts
The presence of higher amounts of proteins retained into the
ER, prompted our investigation into whether such accumulation
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could activate the ER stress and, as a consequence, the UPR
(Walter and Ron, 2011). Therefore, we analyzed the activation
state of components of the UPR signaling, such as PERK
and IRE1, and the expression level of typical marker of ER
stress (Franceschelli et al., 2011; Hiramatsu et al., 2011). To
determine PERK activation, we analyzed by western blotting the
phosphorylated PERK form (p-PERK) and eIF2α form (p-eIF2a)
expressed in the cell extracts obtained from control and PARK20
fibroblasts (Figure 4). In particular, PERK phosphorylation
was recognized throughout immunoblots (Figure 4A) showing
the band-shift of p-PERK in western blot analyses as a
consequence of the higher molecular weight acquired by the
auto-phosphorylation (Harding et al., 1999; Eletto et al., 2016).
As expected, in control cells we did not detect p-PERK form in
basal conditions, but only after treatment with the UPR inducer
thapsigargin (TG) (Figure 4A). Strikingly, p-PERK was highly
detectable in uninduced PARK20 cells, suggesting that the PERK
branch of the UPR was constitutively turned on in PARK20
fibroblasts (Figure 4A). As in control fibroblasts, cell exposure
to the PERK inhibitor GSK abolished kinase activity of the PERK
protein (Figure 4A), confirming that this pathway is activated in
Synj1 mutated cells.
FIGURE 4 | The PERK-dependent pathway of the UPR is up-regulated in PARK20 fibroblasts. (A,B) Western blot analysis of the relative expression of markers of the
PERK-dependent pathway of UPR. Starved HDF (WT) and PARK20 cells were either untreated (C) or treated for 2 h with 1 µM GSK2606414 (GSK) or 500 nM
Thapsigargin (TG) alone (GSK and TG respectively) or in combination (TG + GSK). For TG + GSK samples, a pre-treatment of 30 min with GSK2606414 was
performed prior to the addition of TG. α-Tubulin (TUB) was used as loading control. (B) Densitometry analyses of three independent experiments are shown.
Histogram shows the relative fold induction of the expression of the indicated proteins in the treated samples compared to the control samples. Results are
expressed as mean values ± SD; ∗p ≤ 0.05, ∗∗p ≤ 0.01, Student’s t-test.
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Then, we analyzed the phosphorylation status of elF2α
by using a p-eIF2α antibody, which specifically detects the
phosphorylated form of the protein (Figure 4A) and we found
higher levels of p-eIF2α in PARK20 fibroblasts with respect
control cells (Figures 4A,B). Moreover, PERK inhibitor GSK
was able to reduce p-eIF2α amount in the Synj1 mutated cells
(Figures 4A,B).
Finally, since increased eIF2α phosphorylation induces the
ATF4/CHOP pathway of the ER stress, we analyzed the
expression of ATF4 and CHOP in the PARK20 cells and
found that both proteins enhanced with respect to control cells
(Figures 4A,B). Moreover, after PERK inhibitor incubation ATF4
significantly reduced. Conversely, CHOP was not influenced
by GSK, suggesting the involvement of positive feedback loops
activated downstream to PERK induction (Figures 4A,B).
We also tested whether in the Synj1 mutated cells, the IRE1
arm of the UPR and/or the expression of genes under the
transcriptional control of the ATF6 pathway of the UPR were
equally activated. We found that either the IRE1 endonuclease
activity or expression levels of ATF6-controlled genes in the
PARK20 cells were similar to those detected in control cells
(Supplementary Figure S2).
In summary, our results reveal that in the PARK20 cells the
PERK/eIF2α/ATF4 pathway of the UPR is constantly activated,
presumably as a result of the persistent activation of ER stress
induced by the overload of cargo protein within the ER.
Persistent Activation of the PERK
Pathway of the UPR Induces Oxidative
Stress in PARK20 Cells
The alteration of ER proteostasis and the consequent
accumulation of misfolded proteins within the ER is associated
with the increment of ER protein folding that strongly induces
ROS production (Tu and Weissman, 2004; Santos et al.,
2009). Since NADPH oxidase is one of the key sources of
cytosolic ROS (Lambeth, 2004), we measured the activity of the
NADPH oxidase (NOX) through a quantitative lucigenin-based
luminescence assay. Higher NOX activity was observed in
PARK20 cells compared to control cells at each time point
(Figure 5A), demonstrating that PARK20 fibroblasts exhibited
pronounced oxidative stress.
It is well documented that the UPR could modulate
the oxidative state of the cell, in particular through the
PERK/eIF2α/ATF4 pathway (Amodio et al., 2018). Therefore,
given the activation of the PERK pathway found in PARK20
fibroblasts, we measured the levels of cytosolic Reactive
Oxygen Species (ROS) by dihydroethidium (DHE) fluorescent
probe, in absence or in presence of the PERK inhibitor GSK
(Figure 5B). Upon basal conditions, a significant higher
amount of ROS production was detected in PARK20 cells
with respect to control cells (24000 vs. 38000 a. u.; 1.6
Fold) (Figure 5B). Interestingly, GSK treatment reduced
drastically ROS-derived DHE fluorescence, retrieving it
to the values found in the control cells (Figure 5B).
Alternatively, ROS levels were assessed by confocal microscopy
imaging cells with the redox-sensitive fluorescent probe 2′,7′
dichlorodihydrofluorescein diacetate (DCFH-DA) obtaining
similar results (Figure 5C).
All these data indicate that PERK inhibition significantly
reduces cytosolic ROS generation, thus providing evidence that
the activation of the PERK pathway of UPR is responsible for the
induction of oxidative stress in PARK20 fibroblasts.
Because the PERK pathway of the UPR can also
activate antioxidant factors, such as the neuroprotective
haemeoxygenase-1 (HO-1) enzyme (Alam et al., 1999; Cullinan
et al., 2003; Kensler et al., 2007), we analyzed the expression
level of the HO-1 protein in control and PARK20 fibroblasts
(Figure 5D). Our results clearly show a consistent up-regulation
and PERK-dependant expression of the HO-1 protein in
PARK20 cells, suggesting that PERK activation could also
induce an antioxidant response to oxidative stress in PARK20
cells (Figure 5D).
Furthermore, because mitochondria represent the
major source of intracellular ROS and their dysfunction
is widely reported in PD (Balaban et al., 2005; Lin and
Beal, 2006), we investigated whether the observed cytosolic
ROS overproduction is associated with mitochondria
impairment. Because mitochondrial function is linked to
the overall organization of the mitochondrial network
(Chan, 2012), we examined the mitochondrial morphology
by using the Mitotracker Red CMXRos probe (Figure 6).
The morphology of mitochondrial network is profoundly
altered in PARK20 fibroblasts compared to control cells
(Figure 6). As evident by 3D reconstructions in the patient
cells, mitochondrial network lost the typical interconnected
tubular structure and exhibited thinner and shorter tubules
with many fewer branch points (Figure 6B). Moreover, we
also observed a reduced Mitotracker staining in PARK20
compared to control cells (Figure 6A). Considering that
Mitotracker probe accumulates in mitochondria depending
on its membrane potential (MMP), the reduced staining
suggests a loss in MPP.
All these data indicate that, in addition to the increase in
cytosolic ROS, in the PARK20 cells mitochondrial alteration was
dependent on PERK activation and quite reversed by the PERK
inhibitor GSK2606414 (Figure 6B).
DISCUSSION
In the present work we investigated further into the molecular
events underlying the biogenesis of the juvenile parkinsonism
PARK20, highlighting a role of Synj1 in regulating the early steps
of secretory pathway.
Previous studies have well established that Synj1 is a crucial
player for synaptic vesicle endocytosis and renewal at the
nerve terminals, thanks to its 5-phospatase activity (Cremona
et al., 1999; Kim et al., 2002; Mani et al., 2007; Cao et al.,
2017). Recently, it has been demonstrated that Synj1 controls
endosomal trafficking in different cell types including neuronal
cells, presumably by regulating the of PtdIns3P levels within the
endocytic pathways (Efe et al., 2005; Di Paolo and De Camilli,
2006; Krebs et al., 2013; Fasano et al., 2018).
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FIGURE 5 | Oxidative stress is increased in PARK20 fibroblasts. (A) NADPH oxidase (NOX) activity assay performed in HDF cells (WT) and PARK20 fibroblasts as
reported in the methods. Histogram shows the relative fold change of NOX activity expressed as mean ± SD. Results were obtained from three independent
experiments. (B,C) ROS quantification was carried out by using DHE (B) or DCFH-DA (C) fluorescent probes. HDF cells (WT) and PARK20 fibroblasts were
untreated (C) or treated for 2 h with 1µM GSK2606414 (GSK) and then processed for DHE or DCFH-DA fluorescence quantification as detailed in the methods
section. Histograms show mean values ± SD of DHE or DCFH-DA fluorescence expressed as arbitrary unit (a. u.) and calculated on three independent experiments.
Scale bar 10 µm. (D) Immunoblot detection of HO-1 and densitometric analysis of three independent experiments. Starved HDF (WT) and PARK20 cells were either
untreated (C) or treated for 2 h with 1 µM GSK2606414 (GSK) or 500 nM Thapsigargin (TG) alone (GSK and TG respectively) or in combination (TG + GSK) as
aforementioned. α-Tubulin (TUB) was used as loading control. Representative immunoblotting is shown. Histogram shows the relative fold induction of HO-1
expression in the treated samples compared to the control samples. Results are expressed as mean values ± SD. ∗p ≤ 0.05, ∗∗p ≤ 0.01, Student’s t-test.
Our results reveal a novel role for Synj1, consisting in
the regulation of membrane trafficking at the ER-to-Golgi
boundaries. It is likely that this regulatory function might be
associated to its PtdIns4P phosphatase activity since ER and
Golgi membranes are enriched in this phosphoinositide and the
PtdIns4P phosphatase activity of Synj1 is affected by R258Q
mutation (Krebs et al., 2013). Consistently, similar effect can
be observed when persistent decrease of PtdIns4P hydrolysis is
generated by deletion of the PtdIns4P phosphatase Sac1, the
major lipid 4-phosphatase in yeast and mammals (Foti et al.,
2001; Tahirovic et al., 2005; Liu et al., 2008).
Interestingly, by the use of a newly developed high-
resolution imaging technology Sac1, which has been shown to
shuttle between ER and Golgi in response to different stimuli
(Blagoveshchenskaya and Mayinger, 2009), has been recently
found to reside at the ER-Trans Golgi Network (TGN) contacts
Frontiers in Neuroscience | www.frontiersin.org 9 June 2019 | Volume 13 | Article 673
fnins-13-00673 June 27, 2019 Time: 15:17 # 10
Amodio et al. UPR and Oxidative Stress in PARK20
FIGURE 6 | Mitochondrial network is altered in PARK20 fibroblasts. HDF (WT) and PARK20 cells were seeded on glass coverslips and stained with the mitotracker
red CMXRos probe for 20 min at 37◦C prior to be fixed and processed for immunofluorescence. Serial confocal sections were collected from top and bottom of the
cells. Representative images of single confocal sections (A) and 3D reconstructions of Z-stack acquired to higher magnification (B) are shown. Scale bars: 20 µm.
sites, where its phosphatase activity controls either ER or
Golgi PtdIns4P membrane content (Venditti et al., 2019a,b).
ER can establish membrane contacts with TGN as well as
with endosomal membranes, referred to as ER-endo-lysosomal
contact sites (EELCS) (Eden, 2016; Henne, 2017).
Given the interconnection of Synj1 with the endolysosomal
pathway, an interesting hypothesis, to be tested in future
work, would be to establish, whether Synj1 resides at
EELCS and how EELCS helps Synj1/Sac1 activity to maintain
PtdIns4P homeostasis.
Another finding supporting a role of Synj1 in controlling
the early steps of secretory pathway is the altered distribution
of GM130 and giantin, two Golgi factors also involved in
the ER-to-Golgi trafficking (Alvarez et al., 2001). Furthermore,
PARK20 cells display dramatic changes in the organization
of Golgi membranes. The loss of intact Golgi populations
with concomitant increase in vesiculated and dispersed Golgi
membranes might be due to the unbalanced trafficking or
defective membrane tethering and fusion events, consequent to
the loss of Synj1 PtdIns4P phosphatase activity (Foti et al., 2001;
Tahirovic et al., 2005; D’Agostino et al., 2014, 2018).
Central finding of our work is the discovery that formation
of carrier vesicles at the endoplasmic reticulum exit sites
(ERESs) is largely inhibited. The consequent traffic jam of
secretory proteins within the ER membranes generates the
activation of the PERK pathway of the ER stress/UPR, which
in turn induces oxidative stress and mitochondrial damage.
Therefore, the primary event causing the ER stress activation
might rely on the altered control of the PtdIns4P content
at ER membranes with consequent impairment of carrier
vesicles formation. Indeed, the dynamic control of PtdIns4P
level is necessary to coordinate the progression of both ERES
formation and COPII assembly (Nagaya et al., 2002; Pathre
et al., 2003; Blumental-Perry et al., 2006; Farhan et al., 2008).
In these events, a specific role is played by p125A that, upon
PtdIns4P recognition, promotes the recruitment of Sec16 at
the ERESs, which in turn favors COPII assembly and cargo
export from the ER (Shimoi et al., 2005; Iinuma et al., 2007;
Ong et al., 2010).
Our results indicate that loss of Sac1/Synj1 activity in
the R258Q/R258Q PARK20 cells could profoundly alter these
dynamic events, leading to defective export of secretory
proteins from the ER.
In PARK20 cells the PERK/eIF2α/ATF4 pathway of the UPR
is hyperactive in response to the persistent state of ER stress
induced by the ER overload of cargo proteins. This finding
opens a novel perspective in the understanding of the molecular
events leading to the PARK20 phenotype. The activation of
the PERK pathway of the UPR is a common hallmark of
various neurodegenerative diseases. In particular, as shown
from postmortem analyses in PD patients as well as in animal
models of PD, the activation of the PERK pathway represents
a common cause of death of dopaminergic neuron (Scheper
and Hoozemans, 2015; Gully et al., 2016). In our case, we show
that, in PARK20 cells, prolonged PERK activation generates
a pronounced production of cytosolic ROS, whereas GSK-
mediated inhibition of PERK drastically reduces ROS production.
In this regard, it is worth noting that UPR, through multiple
different pathways, can give rise to either pro-oxidant or
antioxidant response (Malhotra and Kaufman, 2007; Amodio
et al., 2018). In particular, during ER stress the increment of
ER protein folding demand strongly induces ROS production
(Tu and Weissman, 2004; Santos et al., 2009). In this context,
PERK can play the role of a double-edged sword. In fact, in
first instance, the PERK-eIF2α-ATF4 axis operates to restore
ER proteostasis by reducing ER protein load and by inducing
antioxidant pathways through the activation of the transcription
factor nuclear factor erythroid 2-related factor 2 (NRF2) (Alam
et al., 1999; Cullinan et al., 2003; Kensler et al., 2007). On this
line, we found a significant up-regulation of HO-1 expression
in PARK20 cells. On the other hand, the persistent activation of
PERK in condition of unsolved protein misfolding can boost up
ROS production and induce factors of the pro-oxidant signaling
pathway. Among these, the transcription factor CHOP, activated
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downstream to the PERK/eIF2α/ATF4/CHOP pathway, plays an
important role. CHOP promotes the expression of both Ero1
and NOX that are responsible for ROS production during the
oxidative protein folding and ER stress (Li et al., 2010; Anelli et al.,
2012). Accordingly, we found a significant increased expression
of CHOP in PARK20 cells besides the reported increase of
cytosolic ROS. In this regard, it is worth remarking that
normal CHOP expression is not recovered after GSK treatment.
This finding is not surprising, since after its PERK-dependent
activation, CHOP activates other downstream pathways that
positively feedback on CHOP expression. Additionally, it is
important to consider that CHOP triggers the ERo1-IP3R1-
Ca2+/calmodulin-dependent protein kinase II (CaMKII)-NOX2
cascade, in which NOX2 finally induces CHOP expression in
a manner independent by PERK (Li et al., 2010; Anelli et al.,
2012). All in all, our data support co-existence of a PERK-
dependent pro-oxidant and anti-oxidant response. However,
we do not know whether one of them may prevail in the
etiopathological onset of PARK20 and further investigation is
needed in this direction.
Mitochondrial dysfunction is a common hallmark of both
sporadic and genetic PD and is often associated with neuronal cell
death in a number of neurodegenerative diseases (Subramaniam
and Chesselet, 2013). Mitochondria are strictly connected to the
ER via the mitochondrial-associated ER membranes (MAMs)
through which Ca2+, lipids and ROS are transmitted from the ER
to mitochondria (Rainbolt et al., 2014). Our findings support that
the activation of PERK-CHOP pathway during chronic ER stress
can even potentiate MAMs altering the mitochondrial function.
Accordingly, in PARK20 cells we observed that mitochondrial
alteration of MMP and morphology is dependent on PERK
activation and reversed by the PERK inhibitor GSK2606414.
Similar results were obtained in pink1/parkin PD models,
where mitofusin contacts with damaged mitochondria sustain
PERK signaling, while suppression of PERK signaling by using
GSK2606414 or by genetic inhibition has a neuroprotective effect
(Celardo et al., 2016), suggesting common molecular features
between PARK20 and other PD types.
CONCLUSION
In the present work we show that PARK20 fibroblasts display
alteration of the early secretory compartments and impairment
of the ER-to Golgi trafficking leading to PERK activation, OS
induction and mitochondrial dysfunction. Thus, these results
indicate that, beside the role of endosomal system previously
shown (Fasano et al., 2018), defects of early secretory pathway
could contribute to the PARK20 pathogenesis. Together with
our previous findings, our data emphasize the link between
membrane trafficking defects and PD. Moreover, although the
correlation between mitochondrial dysfunction, OS and PERK
activation in PARK20 cells needs to be further investigated,
our current findings open a new lead in studying PD
and phosphoinositide metabolism, providing possible novel
biomarkers that can be used as diagnostic and prognostic tools
for the disease.
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FIGURE S1 | The exocytic trafficking is impaired in PARK20 fibroblasts. (A)
Wild-type and PARK20 fibroblasts, grown on 60 mm dishes, were incubated in
culture medium containing 0.75% serum for 7 h. Then, equal volumes of
corresponding culture mediums were collected, TCA-precipitated, separated by
7.5% SDS-PAGE and revealed by western blotting with collagen IV (COL IV)
antibody (right panel). 1/20 of total was analyzed by 10% SDS-PAGE and total
protein secretion was revealed by Coomassie-Blue staining (left panel). (B)
Wild-type and PARK20 fibroblasts, grown on 60 mm dishes, were biotinylated to
label selectively surface proteins and cell lysates were revealed by western blotting
using HRP-conjugated streptavidin.
FIGURE S2 | Activation of UPR-dependent signaling pathways. (A)
Semi-quantitative RT-PCR of Bip/Grp78 mRNA in HDF (WT) and PARK20
fibroblasts either untreated (0) or treated with 2 µg/ml Tunicamycin (TM) or 500 nM
Thapsigargin (TG) for the indicated times. GAPDH mRNA was used as reference.
One out of three independent experiment is shown. (C) Histogram shows the
relative fold expression of Bip/Grp78 mRNA amplified as in (A) and calculated by
densitometry analysis with ImageJ software. Values are expressed as mean ± SD.
Controls (C) refers to untreated samples. N = 3. (B) XbpI splicing assay performed
on samples treated as in (A). GAPDH mRNA was used as reference. Amplicons
derived from unspliced-XbpI (u) and spliced-XbpI (s) are shown. Numbers refers to
the percent of spliced-XbpI to total XbpI (mean values), quantified by densitometry
analysis with Image J from three independent experiments.
FIGURE S3 | The figure represents the uncut or partially cut filters used to mount
Figure 4A. Predicted MW of proteins are reported on the left of the panels. #
Indicates filters of the same experiment stripped and re-probed with
antibodies as indicated. ∗ Indicates the phosphorylated form of PERK.
FIGURE S4 | The figure represents the uncut filter used to mount Figure 5D.
Predicted MW of the HO-1 protein is reported on the left of the panel.
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